Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Imagine Drucker submitting a grant proposal today titled "Investigating Gila Monster Venom Proteins for Potential Therapeutic Applications." How would reviewers respond to: Unclear commercial potential No obvious connection to existing treatment paradigms High risk of "failure" (most venom studies don't yield drugs) Difficult to measure short-term impact Traditional funding metrics, publication counts, citation indices, immediate clinical relevance, would likely work against such proposals
Pearsons r was employed for correlational analyses in each group
Even though Wegovya higher-dose version of semaglutidewas approved in 2021 for weight loss in obese or overweight adults with at least one weight-related condition, many continued turning to Ozempic off-label due to availability and cost
Gunasundari E, Kumar PS (2017) Higher adsorption capacity of Spirulina platensis alga for Cr(VI) ions removal: parameter optimisation, equilibrium, kinetic and thermodynamic predictions
This is because the risks underscore the need of taking action
